Home › Metastatic Cancer › Maine › West Scarborough
Metastatic Cancer clinical trials in West Scarborough, ME
5 studies for Metastatic Cancer are looking for participants at sites in and around West Scarborough (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RecruitingPhase 2
- MaineHealth Maine Medical Center- Scarborough, Scarborough · 3 mi away
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 1/2
- Maine Medical Center, Scarborough · 3 mi away
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
RecruitingPhase 3
- Maine Medical Center - Scarborough Campus, Scarborough · 3 mi away
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RecruitingPhase 3
- Research Site, Scarborough · 3 mi away
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Scarborough · 3 mi away
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in West Scarborough
- Ovarian Cancer9 studies
- Acute Myeloid Leukemia9 studies
- Breast Cancer7 studies
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Endometrial Cancer6 studies
- Cancer (all types)4 studies
- Burkitt Lymphoma4 studies
- Myeloproliferative Neoplasms4 studies
- Colon Cancer4 studies
- Prostate Cancer4 studies
- Melanoma4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.